XERVYTEG
LIVE

Serial Number

99205147

Owner

MAAT PHARMA

Attorney

Pina Campagna

Filing Date

May 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XERVYTEG Trademark

Serial Number: 99205147 • Registration: 8115056

XERVYTEG is a trademark filed by MAAT PHARMA on May 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MAAT PHARMA (12 trademarks)

70 avenue Tony Garnier

Entity Type: 99

Trademark Details

Filing Date

May 28, 2025

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Pharmaceutical and biopharmaceutical products and preparations for medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction, and for treating cancers and diseases, namely, neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Pharmaceuticals for treatment, maintaining and restoring human health in the field of disturbed microbial community, and treatment for dysbiosis, cancers, and diseases, in the nature of neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Biological preparations in the nature of microorganisms used to treat, maintain and restore human health in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, and diseases in the nature of neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases

Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 17, 2025 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 6, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 28, 2025 MAFR
NEW APPLICATION ENTERED
May 28, 2025 NWAP